Obeticholic acid clinical trials
Also written INT-747 and Ocaliva.
How each study uses obeticholic acid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the obeticholic acid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 27 May 2016 · OCALIVA · NDA 207999 (FDA, Drugs@FDA)
- European Union
- 12 Dec 2016 · Ocaliva · EMEA/H/C/004093 (EMA; now revoked)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
36 studies that test it; most in 2015 (5)
| Year | Studies |
|---|---|
| 2007 | 2 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 21 · Other 15
Intercept Pharmaceuticals (17) · GlaxoSmithKline (2) · Sahlgrenska University Hospital (2) · National Cancer Institute (NCI) (2) · Tanta University (1) · King Edward Medical University (1) · Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (1) · Abhimanyu Garg (1)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test obeticholic acid.
- Sep 2027Obeticholic Acid for Prevention in Barrett's EsophagusPhase 2 · National Cancer Institute (NCI)
Studies
Open first, then newest update. How each study uses obeticholic acid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 36
- Obeticholic Acid for Prevention in Barrett's EsophagusRecruitingPhase 2National Cancer Institute (NCI)NCT04939051Written as Obeticholic AcidHow we know
- Obeticholic Acid Among Chronic HBV Patients with Hepatic Steatosis : Clinical and Portal Doppler OutcomesNot yet recruitingPhase 3Assiut UniversityNCT06691412Written as Obeticholic Acid 5 mgHow we know
- Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBCCompletedPhase 2Intercept PharmaceuticalsNCT05239468Written as Obeticholic Acid 5 mgHow we know
- Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBCTerminatedPhase 2Intercept PharmaceuticalsNCT04594694Written as Obeticholic acidHow we know
- Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomyTerminatedPhase 2/3Intercept PharmaceuticalsNCT06121375Written as OCAHow we know
- Testing Obeticholic Acid for Familial Adenomatous PolyposisTerminatedPhase 2National Cancer Institute (NCI)NCT05223036Written as Obeticholic AcidHow we know
- Comparison of Effectiveness of Obeticholic Acid With Vitamin E in Patients of Non-alcoholic Fatty Liver DiseaseCompletedPhase 2King Edward Medical UniversityNCT07104786Written as Obeticholic Acid 10 MGHow we know
- Comparative Study Between Obeticholic Acid Versus Vitamin E in Patients with Non-alcoholic SteatohepatitisActive, not recruitingPhase 2Tanta UniversityNCT05573204Written as Obeticholic Acid Oral TabletHow we know
- Obeticholic Acid Versus Placebo, in Combination with Ursodeoxycholic Acid in Patients with Primary Biliary CirrhosisCompletedPhase 3Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.NCT06715319Written as OCAHow we know
- Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid TreatmentTerminatedPhase 3Intercept PharmaceuticalsNCT02548351Written as Obeticholic AcidHow we know
- Phase 2 Study of Obeticholic Acid for Lipodystrophy PatientsCompletedPhase 2Abhimanyu GargNCT02430077Written as Obeticholic AcidHow we know
- Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC)TerminatedPhase 2Intercept PharmaceuticalsNCT00550862Written as INT-747How we know
- Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic SteatohepatitisCompletedPhase 3Intercept PharmaceuticalsNCT03439254Written as Obeticholic acid (10 mg)How we know
- Effect of Heavy Alcohol Consumption on Farnesoid X Receptor (FXR) SignalingCompletedNot applicableSuthat LiangpunsakulNCT02654236Written as 10 mg Obeticholic Acid (OCA)How we know
- Obeticholic Acid in Pediatric Subjects With Biliary AtresiaTerminatedPhase 2Intercept PharmaceuticalsNCT05321524Written as OCA 0.1mgHow we know
- Obeticholic Acid in Bile Acid DiarrhoeaCompletedPhase 2Imperial College Healthcare NHS TrustNCT01585025Written as Obeticholic acidHow we know
- Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary CholangitisTerminatedPhase 4Intercept PharmaceuticalsNCT02308111Written as Obeticholic Acid (OCA)How we know
- The Effect of Obeticholic Acid in Healthy VolunteersStatus unknownNot applicableUniversitaire Ziekenhuizen KU LeuvenNCT05740631Written as OcalivaHow we know
- Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Adult ParticipantsCompletedPhase 1GlaxoSmithKlineNCT05133830Written as Obeticholic acidHow we know
- Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic ImpairmentTerminatedPhase 4Intercept PharmaceuticalsNCT03633227Written as Obeticholic Acid (OCA)How we know
Codes
What other systems call obeticholic acid · ClinicalTrials.gg INT004470
- MeSH (NLM) C464660obeticholic acidConfirmed NLM, Wikidata
- UNII (FDA) 0462Z4S4OZOBETICHOLIC ACIDConfirmed FDA, NLM, Wikidata
- RxNorm 1798288Confirmed FDA, Wikidata
- Wikidata Q15708271obeticholic acidConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C80837Obeticholic AcidOne source FDA
- DrugBank DB05990One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C464660 | obeticholic acid | Confirmed NLM, Wikidata |
| UNII (FDA) | 0462Z4S4OZ | OBETICHOLIC ACID | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1798288 | — | Confirmed FDA, Wikidata |
| Wikidata | Q15708271 | obeticholic acid | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C80837 | Obeticholic Acid | One source FDA |
| DrugBank | DB05990 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.